ProtoKinetix, Inc.

Protokinetix, Inc.

Biotechnology • Healthcare • Dalton, OH, United States • PKTX (PNK)

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). Its AFGPs are used in various commercial applications comprising targeted health care solutions, as well as AAGPs are used for applications in ophthalmology, dermatology, transplants, and biomanufacturing areas. The company was formerly known as RJV Network, Inc. and changed its name to ProtoKinetix, Incorporated in July 2003. ProtoKinetix, Incorporated was incorporated in 1999 and is based in Dalton, Ohio.

330 455 4971 109 W Main St, Dalton, OH 44618, United States

Stock Performance (90 Days)

Data through Dec 29, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

ProtoKinetix Appoints Michael Guzzetta as New CEO - The Globe and Mail
The Globe and Mail • Nov 18
Hedge Fund and Insider Trading News: Alan Howard, Cathie Wood, Elliott Management, Bridgewater Associates, Sonim Technologies Inc (SONM), ProtoKinetix, Incorporated (PKTX), and More - Insider Monkey
Insider Monkey • Jul 15
ProtoKinetix (OTCMKTS:PKTX) Stock Price Passes Below Fifty Day Moving Average – Here’s What Happened - Defense World
Defense World • Dec 27
Fifth Street Asset Management (OTCMKTS:FSAM) Stock Passes Above Fifty Day Moving Average – What’s Next? - Defense World
Defense World • Dec 27
Country Garden (OTCMKTS:CTRYY) Shares Pass Below 50 Day Moving Average – Time to Sell? - Defense World
Defense World • Dec 27

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has ProtoKinetix, Inc. had layoffs?
No layoff events have been recorded for ProtoKinetix, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
What industry is ProtoKinetix, Inc. in?
ProtoKinetix, Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is ProtoKinetix, Inc. a publicly traded company?
Yes, ProtoKinetix, Inc. is publicly traded under the ticker symbol PKTX on the PNK. The company has a market capitalization of approximately $0.00 billion.
Where is ProtoKinetix, Inc. headquartered?
ProtoKinetix, Inc. is headquartered in Dalton, OH, United States at 109 W Main St, Dalton, OH 44618, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.